Newly released whitepaper urges employers to break down barriers to leading-edge cancer treatmentsLOS ANGELES, July 11, 2024 /PRNewswire/ -- Private Health Management ("PHM"), a clinically sophisticated complex care management firm, announces the release of its whitepaper, "The Importance of Clinical Trials in Cancer Care." This report highlights the critical role of clinical trials in advancing cancer treatment, improving patient outcomes, and lowering costs for employers.Clinical trials are crucial for testing the safety and efficacy of new medical treatments and interventions. However, access to these trials has often been hindered by the clinical and scientific complexity of identifying and prioritizing appropriate trials. Other challenges impacting enrollment include geographic location, socioeconomic status, and lack of awareness. According to recent estimates, just 7% of patients with cancer in the U.S. have participated in a clinical trial. PHM's trial enrollment rate is 25%, demonstrating the potential for significantly higher participation in clinical trials when care management support is provided."PHM is proud of its ability to bridge the gap between groundbreaking medical research and the patients who may benefit from it," said Ken Tarkoff, Chief Executive Officer, PHM

LOS ANGELES, Nov. 9, 2023 /PRNewswire/ -- Private Health Management (PHM), a clinically sophisticated healthcare navigation firm specializing in providing the best care and outcomes to individuals facing serious and complex conditions, today announced it has appointed Ken Tarkoff as Chief Executive Officer, effective immediately. Tarkoff will also be joining Private Health Management's Board of Directors. Tarkoff succeeds Renae Flanders. Kenneth Tarkoff, Chief Executive Officer, Private Health Management. Tarkoff has more than 30 years of experience driving growth and innovation in healthcare services and digital health. Most recently, he served as CEO of Syapse, a precision medicine analytics company focused on providing real-world evidence and clinical trial solutions

LOS ANGELES, Aug. 15, 2023 /PRNewswire/ -- PHM, a clinically sophisticated healthcare navigation firm specializing in serious and complex conditions, introduces ClearCancerIQ (CCIQ), the first-of-its-kind predictive analytics tool designed to help employers size their company's cancer risk through quantitative analysis of their health plan population. An innovation in PHM's ClearCancer™ suite of solutions, CCIQ enables companies to develop high impact strategies to manage cancer at both the employee and workforce level.For more than 16 years, PHM has delivered exceptional care and outcomes to clients with the most complex cancer cases. ClearCancer is a distinctive cancer care management service for employers invested in the health of their employees. The addition of the CCIQ tool leverages machine learning to enable actionable insights based on cancer type, stage, and workforce demographics across the entire spectrum of cancer care — prevention, diagnosis, treatment, monitoring, and recovery."At PHM, we believe everyone should have access to the best diagnostics, specialists, and treatments," said Renae Flanders, PHM Chief Executive Officer. "By empowering employers with data-driven insights to enhance cancer care, ClearCancerIQ is a powerful new tool to create a healthier workforce and optimize healthcare spend."Cancer is now the highest cost condition for employers according to a 2023 survey by Business Group on Health